LIQUID BIOPSY, CTDNA, EGFR
Patients positive for EGFR mutations benefit from Tyrosine kinase inhibitors. This test uses Whole blood as the specimen (Liquid Biopsy) to detect mutations in Exon 19 (E746_A750del), Exon 20 (T790M) and Exon 21 (L858R). T790M mutation is a resistance mutation which benefits from third generation TKI's like Osimertinib.
Parameter(s) covered : 1
Report Frequency: Sample Mon / Thu by 9 am; Report Fri / Tue
Special Instruction: Physician prescription is mandatory.
Price : ₹ 13500.00
Parameters
- LIQUID BIOPSY, ctDNA, EGFR